Nordic Health Talks
On Wednesday, March 29th, 2023, Nordic Health Talks presents a panel discussion on:
New pharmaceutical rules in the EU – when is the proposal coming and what are the consequences?
The European Commission’s proposal for new pharmaceutical legislation has been the subject of debate ever since a draft was leaked to the press in December 2022. The proposal has been postponed a number of times and has now been further delayed. What will be the consequences for research, innovation, and competitiveness in European life science if the leaked proposal becomes reality?
The panel consists of actors across the Nordic Countries from the European Parliament, authorities, and the pharmaceutical industry.
The conversation will be held in English and live streamed.
- Emma Hannonen, senior advisor at Pharma Industry in Finland
- Jenni Nordborg, head of International Relations at the Swedish Association of the Pharmaceutical Industry
- Joachim Henriksen, Corporate Affairs and Communication Manager at Pfizer in Norway
- Monica Lidberg, director of Regulatory Affairs at the Swedish Medical Products Agency
- Rasmus Beedholm-Ebsen, Phd, senior advisor, Life Science, at The Ministry of Foreign Affairs in Denmark
- Sirpa Pietikäinen, Member of the European Parliament and member of the National Coalition Party, a part of the European People’s Party
Facilitator: Petter Odmark, Reform Society Company
Sign up for the event here: https://www.moleculeconsultancy.com/morgenmoeder/
Gaps & opportunities in women’s health
Event by BioInnovation Institute and Medicon Valley Alliance (HubNordic), December 6, 2022. A day with a lot of insights. Molecule moderated and introduced the day. The introduction was based on the following.
A new Danish Life Science Council shall strengthen public-private collaboration
The Danish Government presents a new national Life Science Council. The council is one of the vital initiatives in the Danish Life Science Strategy from May 2021.
The Danish Government launched a new life science strategy on Friday, 16 April 2021
For the first time in Danish history, a life science strategy was launched not only by the Minister for Industry, Business, and Financial Affairs but also by the Minister for Health, the Minister for Higher Education and Science, and the Minister for Foreign Affairs. This indicates a strong governmental dedication to the strategy. The time horizon for the strategy is 2021-2023. The substance and the financing hereof are to be negotiated with the rest of the Parliament in the near future.
The life science strategy intends to stimulate that Denmark can keep its increasingly leading position in innovative healthcare and welfare solutions as a provider of medicine, biotech, and medtech, and secure and improve a healthcare sector where the patients’ preferences are at the core.
To build cathedrals, we must join forces
‘Sustainability – how can we inspire and learn from each other?’ That was the theme when Chief Sustainability Advisor and Vice President in Novo Nordisk, Susanne Stormer, and Director Tommy Kjelsgaard, Danish Regions met for a dialogue at Molecule Consultancy’s digital breakfast event this week.